A comparison of the effects of two antispastic drugs, tizanidine and baclofen, on synaptic transmission from muscle spindle afferents to spinal interneurones in cats

Acta Physiologica Scandinavica

Volumn 156, Issue 1, 1996, Pages 81-90

  Skoog, B ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Baclofen; Cat; Group II muscle afferents; Muscle spindle; Spasticity; Spinal cord; Synaptic transmission; Tizanidine

Indexed keywords

BACLOFEN; TIZANIDINE;

ANIMAL EXPERIMENT; ARTICLE; CAT; CONTROLLED STUDY; DRUG MECHANISM; ELECTRIC POTENTIAL; INTRAVENOUS DRUG ADMINISTRATION; IONTOPHORESIS; MUSCLE SPINDLE AFFERENT NERVE; MUSCLE TONE; NERVE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; SPASTICITY; SPINAL CORD; SYNAPTIC TRANSMISSION;

EID: 0029916981     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-201X.1996.444159000.x     Document Type: Article

References (47)

1. Anden, N.-E., Jukes, M.G.M., Lundberg, A. & Vyklicky, L. 1966. The effect of DOPA in the spinal cord. 1. Influence on transmission from primary afferents. Acta Physiol Scand 67, 373-386.
2. Bras, H., Cavallari, P., Jankowska, E. & McCrea, D. 1989. Comparison of effects of monoamines on transmission in spinal pathways from group I and II muscle afferents in the cat. Exp Brain Res 76, 27-37.
3. Bras, H., Jankowska, E., Noga, B. & Skoog, B. 1990. Comparison of effects of various types of NA and 5-HT agonists on transmission from group II muscle afferents in the cat. Eur J Neurosci 2, 1029-1039.
4. Burke, D. Gillies, J. Lance, J. 1970. The quadriceps stretch reflex in human spasticity. J Neurol Neurosurg Psychiat 33, 216-223.
5. Burke, D. Gillies, J. Lance, J. 1971. Hamstrings stretch reflex in human spasticity. J Neurol Neurosurg Psychiat 34, 231-235.
6. Butler, T. 1971. The distribution of drugs. In: B. LaDu, G. Mandel & L. Way (eds) Fundamentals of Drug Metabolism, pp. 44-62. Williams and Wilkins, Baltimore.
7. Cavallari, P., Edgley, S. & Jankowska, E. 1987. Postsynaptic actions of midlumbar interneurones on motoneurones of hind-limb muscles in the cat. J Physiol 389, 675-689.
8. Chen, D., Bianchetti, M. & Wiesendanger, M. 1987. The adrenergic agonist tizanidine has differential effects on flexor reflexes of intact and spinalized rat. Neuroscience 23, 641-647.
9. Cox, D. & Dunlap, K. 1992. Pharmacological discrimination of N-type from L-type calcium current and its selective modulation by transmitters. J Neurosci 12(3), 906-914.
10. Curtis, D. Lodge, D. Bornstein, J. & Peet, M. 1981. Selective effects of (-)-baclofen on spinal synaptic transmission in the cat. Exp Brain Res 42, 158-170.
11. Curtis, D. & Malik, R. 1985. The differential effects of baclofen on segmental and descending excitation of spinal interneurones in the cat. Exp Brain Res 58, 333-337.
12. Curtis, D. & Lacey, G. 1994. GABA-B receptor-mediated spinal inhibition. Neuroreport 5, 540-542.
13. Davies, J. 1982. Selective depression of synaptic transmission of spinal neurones in the cat by a new centrally acting muscle relaxant, 5-chloro-4- (2-imidazoline- 2-YL-amino)-2,1,3-benzothiodazole (DS103-282). Br J Pharmac. 76, 473-481.
14. Delwaide, P. & Pennisi, G. 1994. Tizanidine and electrophysiologic analysis of spinal control mechanisms in humans with spasticity. Neurology 44(9), S21-S28.
15. Dunlap, K. & Fischbach, G. 1981. Neurotransmitters decrease the calcium conductance activated by depolarization of embryonic chick sensory neurones. J Physiol 317, 519-535.
16. Edgley, S. & Jankowska, E. 1987a. Field potentials generated by group II muscle afferents in the middle lumbar segments of the cat spinal cord. J Physiol 385, 393-413.
17. Edgley, S. & Jankowska, E. 1987b. An interneuronal relay for group I and II muscle afferents in the middle lumbar segments of the cat spinal cord. J Physiol 389, 647-674.
18. Edwards, F., Harrison, P., Jack, J. & Kullman, D. 1989. Reduction by baclofen of monosynaptic EPSPs in lumbosacral motoneurones of the anaesthetized cat. J Physiol 416, 539-556.
19. Emre, M. 1993. New developments in the medical treatment of spasticity. In: A. Thilmann, D. Burke & W. Rymer (eds) Spasticity : Mechanisms and Management, pp. 372-383. Springer-Verlag, Berlin, Heidelberg.
20. Engberg, I., Källström, I. & Marshall, K. 1972. Double micromanipulator for independent impalements of one neurone with two electrodes. Acta Physiol Scand 84, 4-5.
21. Eriksson, J., Olausson, B. & Jankowska, E. 1994. L-DOPA depresses exaggerated stretch reflexes in spastic patients. Acta Physiol Scand 151, 13A.
22. Eyssette, M., Rohmer, F., Serratrice, G., Warter, J. & Boisson, D. 1988. Multi-centre, double-blind trial of a novel antispastic agent, tizanidine, in spasticity associated with multiple sclerosis. Curr Med Res Opin 10, 699-708.
23. Fournier, E., Meunier, S., Pierrot-Deseilligny, E. & Shindo, M. 1986. Evidence for interneuronally mediated Ia excitatory effects to human quadriceps motoneurones. J Physiol 377, 143-169.
24. Hassan, N. & McLellan, D. 1980. Double-blind comparison of single doses of DS103-282, baclofen and placebo for suppression of spasticity. J Neurol Neurosurg Psychiatr 43, 1132-1136.
25. Heazlewood, V., Symoniw, P., Maruff, P. & Eadie, M. 1983. Tizanidine - initial pharmacokinetic studies in patients with spasticity. Eur J Clin Pharmacol 25, 65-67.
26. Holz, G., Kream, R., Spiegel, A. & Dunlap, K. 1989. G proteins couple alpha-adrenergic and GABAb receptors to inhibition of peptide secretion from peripheral sensory neurons. J Neurosci 9, 657-66.
27. Hoogstraten, M., van der Ploeg, R., van der Burg, W., Vreeling, A., van Marle, S. & Minderhoud, J. 1988. Tizanidine vs. baclofen in the treatment of spasticity in multiple sclerosis patients. Acta Neurol Scand 77, 224-230.
28. Jankowska E. 1993. Monoaminergic inhibitory control of spinal interneurones. In: A. Thilmann, D. Burke & W. Rymer (eds) Spasticity. Mechanisms and Management, pp. 222-232. Springer-Verlag, Berlin, Heidelberg.
29. Kawasaki, K., Takasue, H. & Matsushita, A. 1978. Modulation of spinal reflex activities in acute spinal rats with alpha-adrenergic agonists and antagonists. Jap J Pharmacol 28, 165-168.
30. Klockgether, T., Schwarz, M., Wullner, U., Turski, L. & Sontag, K. 1989. Myorelaxant effect after intrathecal injection of antispastic drugs in rats. Neurosci Lett 97, 221-226.
31. Lundberg, A., Malmgren, K. & Schomburg, E. 1987. Reflex pathways from group II muscle afferents. 1. Distribution and linkage of reflex actions to alpha-motoneurones. Exp Brain Res 65, 271-281.
32. Mailis, A. & Ashby, P. 1990. Alterations in group Ia projections to motoneurons following spinal lesions in man. J Neurophysiol 64, 637-647.
33. Mayer, R., Burke, R., Toop, J., Walmsley, B. & Hodgson, J. 1984. The effect of spinal transection on motor units in cat medial gastrocnemius muscles. Muscle and Nerve 7, 23-31.
34. Medici, M., Pebet, M. & Ciblis, D. 1989. A double-blind, long-term study of tizanidine ('Sirdalud') in spasticity due to cerebrovascular lesions. Curr Med Res Opin 11, 398-407.
35. Nelson, S. & Mendell, L. 1979. Enhancement in Ia-motoneuron synaptic transmission caudal to chronic spinal transection. J Neurophysiol 42, 642-645.
36. Newman, P.M., Nogues, M., Newman, P.K., Weightman, D. & Hudgson, P. 1982. Tizanidine in the treatment of spasticity. Eur J Clin Pharmacol 23, 31-35.
37. Nielsen J. & Hultborn H. 1993. Regulated properties of motoneurons and primary afferents: new aspects on possible spinal mechanisms. In: A. Thilmann, D. Burke & W. Rymer (eds) Spasticity: Mechanisms and Management, pp. 177-192. Springer-Verlag, Berlin, Heidelberg.
38. North, R. & Yoshimura, M. 1984. The actions of noradrenaline on neurones of the rat substantia gelatinosa in vitro. J Physiol 349, 43-55.
39. Padjen, A. & Mitsoglou, G. 1990. Some characteristics of baclofen-evoked responses of primary afferents in frog spinal cord. Brain Res 516, 201-207.
40. Quevedo, J., Eguibar, J., Jimenez, I. & Rudomin, P. 1992. Differential action of (-)-baclofen on the primary afferent depolarization produced by segmental and descending inputs. Exp Brain Res 91, 29-45.
41. Rinne, U. 1980. Tizanidine treatment of spasticity in multiple sclerosis and chronic myelopathy. Current Ther Res 28, 827-836.
42. Schomburg, E. & Steffens, H. 1988. The effect of DOPA and clonidine on reflex pathways from group II muscle afferents to alpha-motoneurones in the cat. Exp Brain Res 71, 442-446.
43. Stien, R., Nordal, H., Oftedal, S. & Slettebö, M. 1987. The treatment of spasticity in multiple sclerosis: A double-blind clinical trial of a new anti-spastic drug tizanidine compared with baclofen. Acta Neurol Scand 75, 190-194.
44. Takayanagi, I., Konno, F., Ishii, C, Takemasa, T., Yanagida, Y., Shimizu, M., Mori, H. & Sugane, H. 1984. Actions of tizanidine on alpha-1- and alpha-2-adrenoceptors in the peripheral tissues. Gen Pharmacol 15, 501-507.
45. Tanabe, M., Ono, H. & Fukuda, H. 1990. Spinal alpha-1-and alpha-2-adrenoceptors mediate facilitation and inhibition of spinal motor transmission, respectively. Jap J Pharmacol 54, 69-77.
46. Thilmann, A., Fellows, S. & Garms, E. 1991. The mechanism of spastic muscle hypertonia : variation in reflex gain over the time course of spasticity. Brain 114, 233-114.
47. Wiesendanger, M., Chapman, C., McPherson, J. & Berger, W. 1984. Neurophysiological Investigations of Tizanidine. In: B. Conrad, R. Benecke & H. Bauer (eds) Die Klinische Wertung der Spastizität, pp. 39-55. Schattauer Verlag, Stuttgart, New York.